世界の上皮成長因子受容体（EGFR）阻害剤市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5726 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、上皮成長因子受容体（EGFR）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（肺がん、大腸がん、乳がん、その他）、用途別市場規模（病院、研究所、研究機関、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・上皮成長因子受容体（EGFR）阻害剤の市場動向 ・企業の競争状況、市場シェア ・上皮成長因子受容体（EGFR）阻害剤の種類別市場規模と予測2016-2027（肺がん、大腸がん、乳がん、その他） ・上皮成長因子受容体（EGFR）阻害剤の用途別市場規模と予測2016-2027（病院、研究所、研究機関、診療所、その他） ・上皮成長因子受容体（EGFR）阻害剤の北米市場規模2016-2027（アメリカ、カナダ） ・上皮成長因子受容体（EGFR）阻害剤の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・上皮成長因子受容体（EGFR）阻害剤のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・上皮成長因子受容体（EGFR）阻害剤の中南米市場規模2016-2027（メキシコ、ブラジル） ・上皮成長因子受容体（EGFR）阻害剤の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Amgen Inc.、AstraZeneca Plc、Eli Lilly and Co.、F. Hoffmann-La Roche Ltd.、Novartis AG） ・結論

The epidermal growth factor receptor (EGFR; ErbB-1; HER1 in humans) is a transmembrane protein that is a receptor for members of the epidermal growth factor family (EGF family) of extracellular protein ligands.
The high efficacy of EGFR inhibitors in the treatment of various types of cancer indications has encouraged researchers to study its use in the treatment of inflammatory and monogenic diseases. Recent in-vitro research studies have suggested that EGFR mutations may cause indications such as eczema, psoriasis, and atherosclerosis. Although these studies are in the early stages of clinical trials, the huge unmet need and further advancements in research are expected to brighten the growth prospects of EGFR inhibitors market vendors in new research areas.

Market Analysis and Insights: Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market
The global Epidermal Growth Factor Receptor (EGFR) Inhibitor market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Epidermal Growth Factor Receptor (EGFR) Inhibitor market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Epidermal Growth Factor Receptor (EGFR) Inhibitor market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Epidermal Growth Factor Receptor (EGFR) Inhibitor market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Epidermal Growth Factor Receptor (EGFR) Inhibitor market.

Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Scope and Market Size
Epidermal Growth Factor Receptor (EGFR) Inhibitor market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Epidermal Growth Factor Receptor (EGFR) Inhibitor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Lung Cancer
Colorectal Cancer
Breast Cancer
Others

Segment by Application
Hospital
Research Institutes and Research Institutions
Clinic
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Amgen Inc.
AstraZeneca Plc
Eli Lilly and Co.
F. Hoffmann-La Roche Ltd.
Novartis AG

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Lung Cancer
1.2.3 Colorectal Cancer
1.2.4 Breast Cancer
1.2.5 Others
1.3 Market by Application
1.3.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Research Institutes and Research Institutions
1.3.4 Clinic
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Perspective (2016-2027)
2.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Growth Trends by Regions
2.2.1 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Historic Market Share by Regions (2016-2021)
2.2.3 Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecasted Market Size by Regions (2022-2027)
2.3 Epidermal Growth Factor Receptor (EGFR) Inhibitor Industry Dynamic
2.3.1 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Trends
2.3.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Drivers
2.3.3 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Challenges
2.3.4 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Epidermal Growth Factor Receptor (EGFR) Inhibitor Players by Revenue
3.1.1 Global Top Epidermal Growth Factor Receptor (EGFR) Inhibitor Players by Revenue (2016-2021)
3.1.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Players (2016-2021)
3.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue
3.4 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Concentration Ratio
3.4.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue in 2020
3.5 Epidermal Growth Factor Receptor (EGFR) Inhibitor Key Players Head office and Area Served
3.6 Key Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Solution and Service
3.7 Date of Enter into Epidermal Growth Factor Receptor (EGFR) Inhibitor Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Epidermal Growth Factor Receptor (EGFR) Inhibitor Breakdown Data by Type
4.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Historic Market Size by Type (2016-2021)
4.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecasted Market Size by Type (2022-2027)

5 Epidermal Growth Factor Receptor (EGFR) Inhibitor Breakdown Data by Application
5.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Historic Market Size by Application (2016-2021)
5.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2016-2027)
6.2 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type
6.2.1 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2021)
6.2.2 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2022-2027)
6.2.3 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2027)
6.3 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application
6.3.1 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2021)
6.3.2 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2022-2027)
6.3.3 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2027)
6.4 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country
6.4.1 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2016-2021)
6.4.2 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2016-2027)
7.2 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type
7.2.1 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2021)
7.2.2 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2022-2027)
7.2.3 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2027)
7.3 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application
7.3.1 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2021)
7.3.2 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2022-2027)
7.3.3 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2027)
7.4 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country
7.4.1 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2016-2021)
7.4.2 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2016-2027)
8.2 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type
8.2.1 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2027)
8.3 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application
8.3.1 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2027)
8.4 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Region
8.4.1 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2016-2027)
9.2 Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type
9.2.1 Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2021)
9.2.2 Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2022-2027)
9.2.3 Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2027)
9.3 Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application
9.3.1 Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2021)
9.3.2 Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2022-2027)
9.3.3 Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2027)
9.4 Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country
9.4.1 Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2016-2021)
9.4.2 Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2016-2027)
10.2 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type
10.2.1 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2027)
10.3 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application
10.3.1 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2027)
10.4 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country
10.4.1 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Amgen Inc.
11.1.1 Amgen Inc. Company Details
11.1.2 Amgen Inc. Business Overview
11.1.3 Amgen Inc. Epidermal Growth Factor Receptor (EGFR) Inhibitor Introduction
11.1.4 Amgen Inc. Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2016-2021)
11.1.5 Amgen Inc. Recent Development
11.2 AstraZeneca Plc
11.2.1 AstraZeneca Plc Company Details
11.2.2 AstraZeneca Plc Business Overview
11.2.3 AstraZeneca Plc Epidermal Growth Factor Receptor (EGFR) Inhibitor Introduction
11.2.4 AstraZeneca Plc Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2016-2021)
11.2.5 AstraZeneca Plc Recent Development
11.3 Eli Lilly and Co.
11.3.1 Eli Lilly and Co. Company Details
11.3.2 Eli Lilly and Co. Business Overview
11.3.3 Eli Lilly and Co. Epidermal Growth Factor Receptor (EGFR) Inhibitor Introduction
11.3.4 Eli Lilly and Co. Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2016-2021)
11.3.5 Eli Lilly and Co. Recent Development
11.4 F. Hoffmann-La Roche Ltd.
11.4.1 F. Hoffmann-La Roche Ltd. Company Details
11.4.2 F. Hoffmann-La Roche Ltd. Business Overview
11.4.3 F. Hoffmann-La Roche Ltd. Epidermal Growth Factor Receptor (EGFR) Inhibitor Introduction
11.4.4 F. Hoffmann-La Roche Ltd. Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2016-2021)
11.4.5 F. Hoffmann-La Roche Ltd. Recent Development
11.5 Novartis AG
11.5.1 Novartis AG Company Details
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG Epidermal Growth Factor Receptor (EGFR) Inhibitor Introduction
11.5.4 Novartis AG Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2016-2021)
11.5.5 Novartis AG Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Lung Cancer
Table 3. Key Players of Colorectal Cancer
Table 4. Key Players of Breast Cancer
Table 5. Key Players of Others
Table 6. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Regions (2016-2021)
Table 10. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Regions (2022-2027)
Table 12. Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Trends
Table 13. Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Drivers
Table 14. Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Challenges
Table 15. Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Restraints
Table 16. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Players (2016-2021)
Table 18. Global Top Epidermal Growth Factor Receptor (EGFR) Inhibitor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor as of 2020)
Table 19. Ranking of Global Top Epidermal Growth Factor Receptor (EGFR) Inhibitor Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Solution and Service
Table 23. Date of Enter into Epidermal Growth Factor Receptor (EGFR) Inhibitor Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Type (2016-2021)
Table 27. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Application (2016-2021)
Table 31. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2022-2027) & (US$ Million)
Table 63. Amgen Inc. Company Details
Table 64. Amgen Inc. Business Overview
Table 65. Amgen Inc. Epidermal Growth Factor Receptor (EGFR) Inhibitor Product
Table 66. Amgen Inc. Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2016-2021) & (US$ Million)
Table 67. Amgen Inc. Recent Development
Table 68. AstraZeneca Plc Company Details
Table 69. AstraZeneca Plc Business Overview
Table 70. AstraZeneca Plc Epidermal Growth Factor Receptor (EGFR) Inhibitor Product
Table 71. AstraZeneca Plc Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2016-2021) & (US$ Million)
Table 72. AstraZeneca Plc Recent Development
Table 73. Eli Lilly and Co. Company Details
Table 74. Eli Lilly and Co. Business Overview
Table 75. Eli Lilly and Co. Epidermal Growth Factor Receptor (EGFR) Inhibitor Product
Table 76. Eli Lilly and Co. Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2016-2021) & (US$ Million)
Table 77. Eli Lilly and Co. Recent Development
Table 78. F. Hoffmann-La Roche Ltd. Company Details
Table 79. F. Hoffmann-La Roche Ltd. Business Overview
Table 80. F. Hoffmann-La Roche Ltd. Epidermal Growth Factor Receptor (EGFR) Inhibitor Product
Table 81. F. Hoffmann-La Roche Ltd. Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2016-2021) & (US$ Million)
Table 82. F. Hoffmann-La Roche Ltd. Recent Development
Table 83. Novartis AG Company Details
Table 84. Novartis AG Business Overview
Table 85. Novartis AG Epidermal Growth Factor Receptor (EGFR) Inhibitor Product
Table 86. Novartis AG Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2016-2021) & (US$ Million)
Table 87. Novartis AG Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type: 2020 VS 2027
Figure 2. Lung Cancer Features
Figure 3. Colorectal Cancer Features
Figure 4. Breast Cancer Features
Figure 5. Others Features
Figure 6. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Research Institutes and Research Institutions Case Studies
Figure 9. Clinic Case Studies
Figure 10. Other Case Studies
Figure 11. Epidermal Growth Factor Receptor (EGFR) Inhibitor Report Years Considered
Figure 12. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Regions: 2020 VS 2027
Figure 15. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Regions (2022-2027)
Figure 16. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Players in 2020
Figure 17. Global Top Epidermal Growth Factor Receptor (EGFR) Inhibitor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue in 2020
Figure 19. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Type (2016-2021)
Figure 20. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Type (2022-2027)
Figure 21. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2016-2027)
Figure 23. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2016-2027)
Figure 24. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Country (2016-2027)
Figure 25. United States Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2016-2027)
Figure 29. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2016-2027)
Figure 30. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Country (2016-2027)
Figure 31. Germany Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Region (2016-2027)
Figure 41. China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2016-2027)
Figure 49. Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2016-2027)
Figure 50. Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Country (2016-2027)
Figure 51. Mexico Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Country (2016-2027)
Figure 57. Turkey Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Amgen Inc. Revenue Growth Rate in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2016-2021)
Figure 61. AstraZeneca Plc Revenue Growth Rate in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2016-2021)
Figure 62. Eli Lilly and Co. Revenue Growth Rate in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2016-2021)
Figure 63. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2016-2021)
Figure 64. Novartis AG Revenue Growth Rate in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

---